首页> 外国专利> PERITONEAL DETERIORATION INHIBITOR CONTAINING RARE SACCHARIDE, PERITONEAL DIALYTIC FLUID AND METHOD FOR PERITONEAL DIALYSIS

PERITONEAL DETERIORATION INHIBITOR CONTAINING RARE SACCHARIDE, PERITONEAL DIALYTIC FLUID AND METHOD FOR PERITONEAL DIALYSIS

机译:包含稀有糖精的腹膜变性抑制剂,腹膜透析液和腹膜透析方法

摘要

PROBLEM TO BE SOLVED: To provide a new peritoneal deterioration inhibitor, a peritoneal dialytic fluid and a method for peritoneal dialysis, inhibiting peritoneal deterioration using a rare saccharide.;SOLUTION: The peritoneal deterioration inhibitor characterized by containing a rare saccharide is provided, wherein the rare saccharide is selected from the group consisting of d-psicose, L-psicose, D-allose, L-sorbose, D-fructose, L-tagatose, D-sorbose, L-fructose and D-tagatose. This peritoneal deterioration inhibitor is characterized by containing, in addition, glucose. This inhibitor is to be used by compounding in a peritoneal dialytic fluid. The peritoneal dialytic fluid is characterized by containing the above inhibitor. This peritoneal dialytic fluid is characterized by containing, in addition, glucose and an electrolyte. The method for peritoneal dialysis is characterized by involving using a dialytic fluid containing an effective amount of the above rare saccharide or its salt.;COPYRIGHT: (C)2010,JPO&INPIT
机译:解决的问题:提供一种新型的腹膜恶化抑制剂,腹膜透析液和腹膜透析的方法,其使用稀有的糖类抑制腹膜恶化。解决方案:提供一种以含有稀有糖类为特征的腹膜恶化抑制剂,其中稀有糖选自:d-阿胶糖,L-阿胶糖,D-阿洛糖,L-山梨糖,D-果糖,L-塔格糖,D-山梨糖,L-果糖和D-塔格糖。该腹膜恶化抑制剂的特征在于还含有葡萄糖。该抑制剂可通过混入腹膜透析液中使用。腹膜透析液的特征在于含有上述抑制剂。该腹膜透析液的特征在于还包含葡萄糖和电解质。腹膜透析方法的特征在于,涉及使用含有有效量的上述稀有糖或其盐的透析液。版权所有:(C)2010,日本特许厅&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号